Taylor Vadset

Ms. Taylor Vadset

orcid

Research Focus & Metrics

Academic Career Length

8Years (2019-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
30 September 2019 in Nature Communications
Verified
Journal Article
Open access
PDF file
SWSarah M. Waldherr
Sarah M. Waldherr
TSTimothy J. Strovas
Timothy J. Strovas
TVTaylor Vadset
Taylor Vadset
NLNicole F. Liachko
Nicole F. Liachko
BKBrian C. Kraemer
Brian C. Kraemer
To endure over the organismal lifespan, neurons utilize multiple strategies to achieve protein homeostasis (proteostasis). Some homeostatic mechanisms act in a subcellular compartment-specific manner, but others exhibit trans-compartmental mechanisms of proteostasis. To identify pathways protecting neurons from pathological tau protein, we employed a transgenic Caenorhabditis elegans model of human tauopathy exhibiting proteostatic disruption. We show normal functioning of the endoplasmic reticulum unfolded protein response (UPRER) promotes clearance of pathological tau, and loss of the three UPRER branches differentially affects tauopathy phenotypes. Loss of function of xbp-1 and atf-6 genes, the two main UPRER transcription factors, exacerbates tau toxicity. Furthermore, constitutive activation of master transcription factor XBP-1 ameliorates tauopathy phenotypes. However, both ATF6 and PERK branches of the UPRER participate in amelioration of tauopathy by constitutively active XBP-1, possibly through endoplasmic reticulum-associated protein degradation (ERAD). Understanding how the UPRER modulates pathological tau accumulation will inform neurodegenerative disease mechanisms.

14 January 2022 in Metabolites
Verified
Journal Article
Open access
PDF file
TVTaylor Vadset
Taylor Vadset
ARAjay Rajaram
Ajay Rajaram
CHChuan-Heng Hsiao
Chuan-Heng Hsiao
MKMIRIAH KEMIGISHA
MIRIAH KEMIGISHA
Joshua Jayz MagombeJoshua Jayz Magombe
Joshua Jayz Magombe
Pei-Yi LinPei-Yi Lin
Pei-Yi Lin
Infant hydrocephalus poses a severe global health burden; 80% of cases occur in the developing world where patients have limited access to neurosurgical care. Surgical treatment combining endoscopic third ventriculostomy and choroid plexus cauterization (ETV/CPC), first practiced at CURE Children’s Hospital of Uganda (CCHU), is as effective as standard ventriculoperitoneal shunt (VPS) placement while requiring fewer resources and less post-operative care. Although treatment focuses on controlling ventricle size, this has little association with treatment failure or long-term outcome. This study aims to monitor the progression of hydrocephalus and treatment response, and investigate the association between cerebral physiology, brain growth, and neurodevelopmental outcomes following surgery. We will enroll 300 infants admitted to CCHU for treatment. All patients will receive pre/post-operative measurements of cerebral tissue oxygenation (SO2), cerebral blood flow (CBF), and cerebral metabolic rate of oxygen consumption (CMRO2) using frequency-domain near-infrared combined with diffuse correlation spectroscopies (FDNIRS-DCS). Infants will also receive brain imaging, to monitor tissue/ventricle volume, and neurodevelopmental assessments until two years of age. This study will provide a foundation for implementing cerebral physiological monitoring to establish evidence-based guidelines for hydrocephalus treatment. This paper outlines the protocol, clinical workflow, data management, and analysis plan of this international, multi-center trial.

15 August 2024 in World Neurosurgery
Verified
Journal Article
Closed access
MEMuhammed Amir Essibayi
Muhammed Amir Essibayi
STSalem M. Tos
Salem M. Tos
TVTaylor Vadset
Taylor Vadset
MBMandana Behbahani
Mandana Behbahani
PLPatrick A. Lasala
Patrick A. Lasala
JSJason P. Sheehan
Jason P. Sheehan